MACROGENICS, INC. Cost of Revenue
MACROGENICS, INC. (MGNX) reported Cost of Revenue of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-03-09
- MACROGENICS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MACROGENICS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MACROGENICS, INC. cost of goods and services sold for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- MACROGENICS, INC. cost of goods and services sold for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- MACROGENICS, INC. cost of goods and services sold for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- MACROGENICS, INC. cost of goods and services sold for fiscal 2024 was $847.00K, a 36.83% increase from fiscal 2023.
- MACROGENICS, INC. cost of goods and services sold for fiscal 2023 was $619.00K, a 81.53% decline from fiscal 2022.
- MACROGENICS, INC. cost of goods and services sold for fiscal 2022 was $3.35M, a 26.41% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $233.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $233.00K derived: sum of 3 quarters · filed 2026-03-09 | $401.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $233.00K derived: sum of 2 quarters · filed 2026-03-09 | $401.00K derived: sum of 3 quarters · filed 2026-03-09 | $577.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $401.00K derived: sum of 2 quarters · filed 2026-03-09 | $577.00K derived: sum of 3 quarters · filed 2026-03-09 | $847.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $168.00K 10-Q · filed 2025-11-12 | $344.00K derived: sum of 2 quarters · filed 2025-11-12 | $614.00K 10-Q · filed 2025-11-12 | $777.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | $176.00K 10-Q · filed 2025-08-14 | $446.00K 10-Q · filed 2025-08-14 | $609.00K derived: sum of 3 quarters · filed 2026-03-09 | $694.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $270.00K 10-Q · filed 2025-05-13 | $433.00K derived: sum of 2 quarters · filed 2026-03-09 | $518.00K derived: sum of 3 quarters · filed 2026-03-09 | $776.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $248.00K derived: sum of 2 quarters · filed 2026-03-09 | $506.00K derived: sum of 3 quarters · filed 2026-03-09 | $619.00K 10-K · filed 2026-03-09 |
| 2023-09-30 | $85.00K 10-Q · filed 2024-11-05 | $343.00K derived: sum of 2 quarters · filed 2024-11-05 | $456.00K 10-Q · filed 2024-11-05 | $572.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | $258.00K 10-Q · filed 2024-08-06 | $371.00K 10-Q · filed 2024-08-06 | $487.00K derived: sum of 3 quarters · filed 2025-03-20 | $3.49M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | $113.00K 10-Q · filed 2024-05-09 | $229.00K derived: sum of 2 quarters · filed 2025-03-20 | $3.24M derived: sum of 3 quarters · filed 2025-03-20 | $3.42M derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $3.12M derived: sum of 2 quarters · filed 2025-03-20 | $3.30M derived: sum of 3 quarters · filed 2025-03-20 | $3.35M 10-K · filed 2025-03-20 |
| 2022-09-30 | $3.01M 10-Q · filed 2023-11-06 | $3.19M derived: sum of 2 quarters · filed 2023-11-06 | $3.23M 10-Q · filed 2023-11-06 | $4.18M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $180.00K 10-Q · filed 2023-08-09 | $228.00K 10-Q · filed 2023-08-09 | $1.18M derived: sum of 3 quarters · filed 2024-03-07 | $2.84M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $48.00K 10-Q · filed 2023-05-09 | $995.00K derived: sum of 2 quarters · filed 2024-03-07 | $2.66M derived: sum of 3 quarters · filed 2024-03-07 | $2.68M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $947.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.61M derived: sum of 2 quarters · filed 2024-03-07 | $2.63M derived: sum of 3 quarters · filed 2024-03-07 | $2.65M 10-K · filed 2024-03-07 |
| 2021-09-30 | $1.67M 10-Q · filed 2022-11-03 | $1.69M derived: sum of 2 quarters · filed 2022-11-03 | $1.70M 10-Q · filed 2022-11-03 | $1.70M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $22.00K 10-Q · filed 2022-08-08 | $39.00K 10-Q · filed 2022-08-08 | $39.00K derived: sum of 3 quarters · filed 2023-03-15 | $39.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-03 | $17.00K derived: sum of 2 quarters · filed 2023-03-15 | $17.00K derived: sum of 3 quarters · filed 2023-03-15 | $17.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |